Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 3 Clinical Trial of Postoperative Radiotherapy Versus Postoperative Surveillance for Clinical Low-Risk, Molecular High-Risk Meningioma and Longitudinal Surveillance for Clinical and Molecular Low-Risk Meningioma

NCT07785687 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT07785687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07785687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 3 Clinical Trial of Postoperative Radiotherapy Versus Postoperative Surveillance for Clinical Low-Risk, Molecular High-Risk Meningioma and Longitudinal Surveillance for Clinical and Molecular Low-Risk Meningioma
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 28, 2027
Completion date
June 30, 2040
Enrollment
464 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

grade 1 meningioma, grade 2 meningioma, recurrent grade 1 meningioma